Microsatellite Instability and Loss of Heterozygosity in Mammary Carcinoma
Author Information
Author(s): EK Dillon, WB de Boer, JM Papadimitriou, GR Turbett
Primary Institution: Royal Perth Hospital and University of Western Australia
Hypothesis
The study investigates the role of microsatellite instability (MSI) and loss of heterozygosity (LOH) in the progression of mammary carcinoma.
Conclusion
The study found that microsatellite instability is generally not a significant feature of mammary neoplasms and does not play a major role in their development.
Supporting Evidence
- High rates of loss on chromosomes 17p, 17q, and Xq indicate these regions contain important genes for mammary carcinogenesis.
- The rate of microsatellite instability observed was uniformly low across all lesion types.
- Only 10.8% of breast cancer patients showed any microsatellite instability.
- Loss of heterozygosity was observed in 54.2% of patients, indicating it may be a more common mechanism in breast cancer.
Takeaway
The researchers looked at how certain genetic changes happen in breast cancer, and they found that most of the time, these changes don't really help the cancer grow.
Methodology
DNA samples from both normal and lesional tissue from 120 patients were analyzed for microsatellite instability and loss of heterozygosity.
Limitations
The study's findings may be limited by the variability in microsatellite markers used across different studies.
Participant Demographics
The study included 120 patients with various types of mammary lesions, including epithelial hyperplasia, carcinoma in situ, invasive carcinoma, and metastatic carcinoma.
Want to read the original?
Access the complete publication on the publisher's website